Welcome to our dedicated page for Sonendo news (Ticker: SONX), a resource for investors and traders seeking the latest updates and insights on Sonendo stock.
News for Sonendo, Inc. (SONX) centers on its activities as a commercial-stage medical technology and dental technology company. Sonendo develops and manufactures the GentleWave System, a platform for treating tooth decay and performing root canal therapy by cleaning and disinfecting microscopic spaces within teeth without removing tooth structure. Company news often reiterates this focus on saving teeth from tooth decay and improving clinical outcomes in endodontic care.
Investors and dental professionals following Sonendo’s news can expect regular updates on financial performance, including revenue from GentleWave consoles, procedure instruments and other products, as well as disclosures on gross margin, operating loss, adjusted EBITDA loss and free cash flow burn. The company has reported on a strategic reset and restructuring efforts aimed at stabilizing revenue, expanding margins and reducing operating expenses and cash burn.
Sonendo’s news flow also covers product and technology developments, such as the launch of ProControl for the GentleWave G4 System. This software update is described as enabling optimized cleaning of complex anatomy, increased procedure efficiency and the ability to adjust procedure fluid concentration levels when using the CleanFlow procedure instrument. Such announcements highlight the company’s focus on evolving its GentleWave platform and supporting personalized treatment in endodontics.
Additional news items may include capital-raising and financing transactions, such as private placements of common stock and amendments to credit facilities, as well as strategic transactions like the Asset Purchase Agreement to acquire Biolase assets through a bankruptcy court process and updates on related patent litigation. Leadership and organizational updates, including changes in operational roles, also appear in Sonendo’s press releases. For a consolidated view of these developments, this news page aggregates Sonendo’s public announcements and market-facing communications.
Sonendo, Inc. (NYSE: SONX) is set to release its financial results for Q3 2022 on November 9, 2022, after market close. The management will hold a conference call at 1:30 p.m. PT to discuss results. The GentleWave® System, developed by Sonendo, aims to enhance dental procedures by cleaning tooth decay without removing tooth structure, offering improved patient outcomes. The company also owns TDO® Software, which streamlines endodontic practice management.
Sonendo has launched the GentleWave G4 System, an advanced dental technology aimed at enhancing root canal treatment. The system features improved workflow, broad-spectrum acoustic energy, and advanced fluid dynamics for superior cleaning and patient outcomes. A recent clinical trial indicated that 99.5% of patients experienced minimal to no pain during the procedure. The G4 system is designed for future upgradeability and operational efficiency with features like battery backup and multi-operatory connectivity, enhancing both patient care and practice productivity.
Sonendo, Inc. (NYSE: SONX) has announced its second annual EndoCon, an endodontic conference focused on innovation, to take place in San Diego from October 20-22. The event will offer hands-on learning, lectures, and networking opportunities for clinicians and staff, featuring keynote speakers Joel Goldberg and Jessica Metcalfe. With over 400 attendees last year, EndoCon aims to enhance knowledge and skills in modern endodontics through interactive sessions and industry expert insights.
Summary not available.
Sonendo, Inc. (NYSE: SONX) announced a private placement of common stock and pre-funded warrants, generating $63 million in gross proceeds. Key investors include Pura Vida Investments and First Light Asset Management. The financing bolsters the company’s balance sheet and supports its mission of improving patient care through innovative dental technologies. Sonendo plans to utilize the proceeds for commercialization efforts, product expansion, and general corporate purposes. The placement is expected to close on September 27, 2022.
Sonendo, Inc. (NYSE: SONX), a dental technology leader, announced its sponsorship of the inaugural Women in Endodontics summit in Tucson, Arizona, from September 23-25. The summit features educational sessions led by notable endodontists and aims to foster networking and professional growth among women in the field. Noteworthy speakers include Dr. Srikumar S. Rao and Dr. Jessica E. Metcalfe. The initiative aligns with Sonendo's commitment to promoting leadership opportunities for women in dentistry, driving inclusivity within the industry.
Sonendo, Inc. (NYSE: SONX), a dental technology leader, will participate in the Morgan Stanley 20th Annual Global Healthcare Conference on September 13 at 2:55 p.m. ET. An audio webcast of the presentation will be accessible via the company’s website. Sonendo is known for its GentleWave® System, which treats tooth decay using innovative technology that preserves tooth structure while enhancing clinical outcomes.
The GentleWave System improves cleaning efficacy, healing rates, and minimizes post-operative pain, thus optimizing workflow for dental practices.
Sonendo reported a strong Q2 2022, achieving $10.5 million in total revenue, a 32% increase from the previous year. The GentleWave console revenue rose to $2.7 million, and procedure instrument revenue hit $4.8 million. Despite a slight dip in gross margin to 24% due to supply chain issues, operational efficiency is improving. The company launched the CleanFlow Technology in April 2022 and has an install base of approximately 900 units. Sonendo anticipates full-year revenue between $40.5 million and $42.5 million, indicating 22% to 28% annual growth.
Sonendo, a leading dental technology company, will release its second quarter 2022 financial results on August 10, 2022, after market close. A conference call is scheduled for 1:30 PM PT / 4:30 PM ET to discuss the results. Investors can access the call by dialing (844) 200-6205 domestically or (929) 526-1599 internationally, using access code: 283383. The company is known for its GentleWave® System, which innovatively treats tooth decay and enhances dental practice workflows.
Sonendo (NYSE: SONX) has appointed Joanne Lindberg as Vice President of Sales for North America to accelerate sales growth for its GentleWave® System. With over 20 years of experience in the technology and medical device sectors, Lindberg's leadership aims to increase market penetration in the U.S. and Canada. She has a proven track record in high-performing teams and strategic sales execution. CEO Michael Smith expressed confidence in Lindberg's ability to drive the company’s commercial strategy. The GentleWave System addresses over 17 million root canal procedures annually, presenting significant growth opportunities.